Country

Merz Holding Board

The Merz Holding Board of Merz Pharma GmbH & Co. KGaA advises the Management Board; its duties include approving major projects, such as acquisitions and extraordinary transactions. The Merz Holding Board has four members: two are appointed from the ranks of the Supervisory Board, and two others are members of the shareholder families

Philip Burchard

CEO and Chairman, Merz Group

Mr. Burchard is CEO and Chairman of the Shareholders Council of Merz Group. Merz Group is a diversified, privately-held healthcare company with key business areas medical aesthetics, therapeutics and consumer care.

Mr. Burchard is CEO and Chairman of the Shareholders Council of Merz Group. Merz Group is a diversified, privately-held healthcare company with key business areas medical aesthetics, therapeutics and consumer care.

Mr. Burchard joined Merz as CEO in July 2012 and assumed the additional responsibility as Chairman of the Shareholders Council in November 2019.

Under his leadership, Merz has focused its strategy on aesthetics and specialty neurology, leading to a realignment of its global R&D organization, the acquisitions of numerous companies in the aesthetics space, and a geographic expansion in Asia Pacific, Latin America and the Middle East.

Mr. Burchard has more than 30 years of experience in the pharmaceutical industry, having worked in sales and marketing, as well as general management roles, in six different countries across Asia, Europe, Latin America and the United States.

Dr. Christian Holzherr

Chairman of the Supervisory Board, Member of the Merz Holding Board and Chairman of the Tax and Audit Committee

Long track record of CEO and CFO positions in the pharmaceutical and medical device industry

Long track record of CEO and CFO positions in the pharmaceutical and medical device industry

Christian Baatz

Member of the shareholder families (fourth generation shareholder)

Master’s degree in Business Administration

Master’s degree in Business Administration

Andreas Meyer

Member of the shareholder families (fourth generation).

Supervisory Board

The Supervisory Board of Merz Pharma GmbH & Co. KGaA oversees the Management Board and is involved in decisions of major importance for the company. The following four members sit on the Supervisory Board:

Dr. Christian Holzherr, Chairman of the Supervisory Board Merz Pharma GmbH & Co. KGaA
Dr. Patricia Walker, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
Christian Baatz, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA
Andreas Meyer, Member of the Supervisory Board Merz Pharma GmbH & Co. KGaA